Clopidogrel plus aspirin vs aspirin alone in patients with acute mild to moderate stroke: the ATAMIS randomized clinical trial

HS Chen, Y Cui, XH Wang, YT Ma, J Han… - JAMA …, 2024 - jamanetwork.com
Importance Dual antiplatelet therapy has been demonstrated to be superior to single
antiplatelet in reducing recurrent stroke among patients with transient ischemic attack or …
被引用次数：1 相关文章

Clopidogrel Plus Aspirin vs Aspirin Alone in Patients With Acute Mild to Moderate Stroke

HS Chen, Y Cui, XH Wang, YT Ma, J Han… - JAMA …, 2024 - archive.lstmed.ac.uk
Importance Dual antiplatelet therapy has been demonstrated to be superior to single
antiplatelet in reducing recurrent stroke among patients with transient ischemic attack or …

Clopidogrel Plus Aspirin vs Aspirin Alone in Patients With Acute Mild to Moderate Stroke: The ATAMIS Randomized Clinical Trial.

HS Chen, Y Cui, XH Wang, YT Ma, J Han… - JAMA …, 2024 - search.ebscohost.com
Abstract Key Points: Question: Is dual antiplatelet therapy superior to aspirin alone in
patients with acute mild to moderate ischemic stroke? Findings: In this randomized clinical …

Clopidogrel Plus Aspirin vs Aspirin Alone in Patients With Acute Mild to Moderate Stroke: The ATAMIS Randomized Clinical Trial.

HS Chen, Y Cui, XH Wang, YT Ma, J Han… - JAMA …, 2024 - europepmc.org
Clopidogrel Plus Aspirin vs Aspirin Alone in Patients With Acute Mild to Moderate Stroke: The
ATAMIS Randomized Clinical Trial. - Abstract - Europe PMC Sign in | Create an account …

Clopidogrel Plus Aspirin vs Aspirin Alone in Patients With Acute Mild to Moderate Stroke: The ATAMIS Randomized Clinical Trial

HS Chen, Y Cui, XH Wang, YT Ma, J Han, YJ Duan… - 2024 - pubmed.ncbi.nlm.nih.gov
Importance Dual antiplatelet therapy has been demonstrated to be superior to single
antiplatelet in reducing recurrent stroke among patients with transient ischemic attack or …

Clopidogrel Plus Aspirin vs Aspirin Alone in Patients With Acute Mild to Moderate Stroke

HS Chen, Y Cui, XH Wang, YT Ma, J Han… - JAMA …, 2024 - archive.lstmed.ac.uk
Importance Dual antiplatelet therapy has been demonstrated to be superior to single
antiplatelet in reducing recurrent stroke among patients with transient ischemic attack or …